von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke

Research output: Contribution to journalReview articlepeer-review

81 Scopus citations

Abstract

von Willebrand factor (VWF) and platelets are key mediators of normal hemostasis. At sites of vascular injury, VWF recruits platelets via binding to the platelet receptor glycoprotein Ibα (GPIbα). Over the past decades, it has become clear that many hemostatic factors, including VWF and platelets, are also involved in inflammatory processes, forming intriguing links between hemostasis, thrombosis, and inflammation. The so-called “thrombo-inflammatory” nature of the VWF-platelet axis becomes increasingly recognized in different cardiovascular pathologies, making it a potential therapeutic target to interfere with both thrombosis and inflammation. In this review, we discuss the current evidence for the thrombo-inflammatory activity of VWF with a focus on the VWF-GPIbα axis and discuss its implications in the setting of ischemic stroke.

Original languageEnglish
Article number2884
JournalFrontiers in immunology
Volume10
DOIs
StatePublished - Dec 17 2019

Keywords

  • ADAMTS13
  • ischemic stroke
  • platelet glycoprotein Ibα
  • thromboinflammation
  • von Willebrand factor

Fingerprint

Dive into the research topics of 'von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke'. Together they form a unique fingerprint.

Cite this